About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Dead Space Evaluation in Pulmonary Hypertension | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT02892981

Dead Space Evaluation in Pulmonary Hypertension

Aim of the study is to evaluate the role of chemoreceptor activity and ventilation perfusion mismatch on the genesis of exercise induced hyperventilation in Pulmonary hypertension patients. So the inv...

Lead sponsor: Centro Cardiologico Monzino•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Centro Cardiologico Monzino

Age

18 - 80 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•age ≥18 and ≤ 80 years
•ability to understand the research protocol and willing to sign the study informed consent
•diagnosis of pulmonary arterial hypertension belonging to Class I and IV
•stable haemodynamic status and optimized medical treatment since at least 2 months
•ability to perform maximal cardiopulmonary exercise test and pulmonary diffusing capacity for carbon monoxide evaluation

Exclusion Criteria

•relevant comorbidities
•usual contraindications for cardiopulmonary exercise test
•pulmonary hypertension associated to left heart and pulmonary disease, congenital heart diseases with evident cardiac shunts.

Related studies

RECRUITINGPhase 2

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

NCT07333183 · Pulmonary Hypertension, Interstitial Lung Disease (ILD), and more

RECRUITINGPhase 1/2

Feasibility of Semaglutide in Advanced Lung Disease

NCT05746039 · Obesity, Interstitial Lung Disease, and more

Evaluation of the BMPR2-Activin Signaling Pathway in Group II Pulmonary Hypertension.

NCT07537517 · Pulmonary Hypertension Due to Left Heart Disease, Pulmonary Hypertension (PH), and more

RECRUITINGPhase 1

Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension

NCT06770023 · Lung Transplant, Pulmonary Hypertension

RECRUITINGPhase 2

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

NCT07073820 · Pulmonary Hypertension

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 8, 2016Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment18

Start dateJan 2015

Last updatedSep 8, 2016

Condition

Pulmonary Hypertension

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 8, 2016Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions